Bcl-xl does not have to bind Bax to protect T cells from death

Journal of Experimental Medicine

Volumn 203, Issue 13, 2006, Pages 2953-2961

  Liu, Xinqi ^a,b,d   Zhu, Yanan ^c,e   Dai, Shaodong ^a,b   White, Janice ^a,b   Peyerl, Fred ^a,b   Kappler, John W ^a,b,c   Marrack, Philippa ^a,b,c  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d PURDUE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL XL;

ARTICLE; CELL CYCLE; CELL DEATH; CELL PROTECTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEOMICS; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CELL LINE; CRYSTALLOGRAPHY, X-RAY; ENTEROTOXINS; IMMUNOPRECIPITATION; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MODELS, MOLECULAR; MUTATION; PEPTIDE HYDROLASES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; T-LYMPHOCYTES; TRANSFECTION;

EID: 33845886413     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20061151     Document Type: Article

References (48)

1. Pape, K.A., A. Khoruts, A. Mondino, and M.K. Jenkins. 1997. Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4+ T cells. J. Immunol. 159:591-598.
2. Hildeman, D.A., Y. Zhu, T.C. Mitchell, P. Bouillet, A. Strasser, J. Kappler, and P. Marrack. 2002. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity. 16:759-767.
3. McDonnell, T.J., N. Deane, F.M. Platt, G. Nunez, U. Jaeger, J.P. McKearn, and S.J. Korsmeyer. 1989. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 57:79-88.
4. Sentman, C.L., J.R. Shutter, D. Hockenbery, O. Kanagawa, and S.J. Korsmeyer. 1991. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell. 67:879-888.
5. Strasser, A., A.W. Harris, and S. Cory. 1991. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:889-899.
6. Vaux, D.L., S. Cory, and J.M. Adams. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:440-442.
7. Petschner, F., C. Zimmerman, A. Strasser, D. Grillot, G. Nunez, and H. Pircher. 1998. Constitutive expression of Bcl-xL or Bcl-2 prevents peptide antigen-induced T cell deletion but does not influence T cell homeostasis after a viral infection. Eur. J. Immunol. 28:560-569.
8. Rathmell, J.C., T. Lindsten, W.X. Zong, R.M. Cinalli, and C.B. Thompson. 2002. Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat. Immunol. 3:932-939.
9. Zhu, Y., X. Liu, D. Hildeman, F.W. Peyerl, J. White, E. Kushnir, J. Kappler, and P. Marrack. 2006. Bax does not have to adopt its final form to drive T cell death. J. Exp. Med. 203:1147-1152.
10. Bouillet, P., D. Metcalf, D.C. Huang, D.M. Tarlinton, T.W. Kay, F. Kontgen, J.M. Adams, and A. Strasser. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 286:1735-1738.
11. Boyd, J.M., G.J. Gallo, B. Elangovan, A.B. Houghton, S. Malstrom, B.J. Avery, R.G. Ebb, T. Subramanian, T. Chittenden, R.J. Lutz, et al. 1995. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene. 11:1921-1928.
12. Zha, H., C. Aime-Sempe, T. Sato, and J.C. Reed. 1996. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. Biol. Chem. 271:7440-7444.
13. Wei, M.C., T. Lindsten, V.K. Mootha, S. Weiler, A. Gross, M. Ashiya, C.B. Thompson, and S.J. Korsmeyer. 2000. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14:2060-2071.
14. Yamaguchi, H., and H.G. Wang. 2002. Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL. J. Biol. Chem. 277:41604-41612.
15. Morishima, N., K. Nakanishi, K. Tsuchiya, T. Shibata, and E. Seiwa. 2004. Translocation of Bim to the endoplasmic reticulum (ER) mediates ER stress signaling for activation of caspase-12 during ER stress-induced apoptosis. J. Biol. Chem. 279:50375-50381.
16. Wang, K., A. Gross, G. Waksman, and S.J. Korsmeyer. 1998. Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing. Mol. Cell. Biol. 18:6083-6089.
17. Chipuk, J.E., and D.R. Green. 2004. Cytoplasmic p53: bax and forward. Cell Cycle. 3:429-431.
18. Burri, S.H., C.N. Kim, G. Fang, B.S. Chang, C. Perkins, W. Harris, L.W. Davis, C.B. Thompson, and K.N. Bhalla. 1999. 'Loop' domain deletional mutant of Bcl-xL is as effective as p29Bcl-xL in inhibiting radiation-induced cytosolic accumulation of cytochrome c (cyt c), caspase-3 activity, and apoptosis. Int J Radiat Oncol Biol Phys. 43:423-430.
19. Chang, B.S., A.J. Minn, S.W. Muchmore, S.W. Fesik, and C.B. Thompson. 1997. Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO J. 16:968-977.
20. Muchmore, S.W., M. Sattler, H. Liang, R.P. Meadows, J.E. Harlan, H.S. Yoon, D. Nettesheim, B.S. Chang, C.B. Thompson, S.L. Wong, et al. 1996. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature. 381:335-341.
21. Petros, A.M., D.G. Nettesheim, Y. Wang, E.T. Olejniczak, R.P. Meadows, J. Mack, K. Swift, E.D. Matayoshi, H. Zhang, C.B. Thompson, and S.W. Fesik. 2000. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci. 9:2528-2534.
22. Liu, X., S. Dai, Y. Zhu, P. Marrack, and J.W. Kappler. 2003. The structure of a Bcl-xL/Bim fragment complex: implications for Bim function. Immunity. 19:341-352.
23. Zhu, Y., B.J. Swanson, M. Wang, D.A. Hildeman, B.C. Schaefer, X. Liu, H. Suzuki, K. Mihara, J. Kappler, and P. Marrack. 2004. Constitutive association of the proapoptotic protein Bim with Bcl-2-related proteins on mitochondria in T cells. Proc. Natl. Acad. Sci. USA. 101:7681-7686.
24. Hsu, Y.T., and R.J. Youle. 1997. Nonionic detergents induce dimerization among members of the Bcl-2 family. J. Biol. Chem. 272:13829-13834.
25. Ruffolo, S.C., and G.C. Shore. 2003. BCL-2 selectively interacts with the BID-induced open conformer of BAK, inhibiting BAK auto-oligomerization. J. Biol. Chem. 278:25039-25045.
26. Figueroa, B., Jr., T.M. Sauerwald, G.A. Oyler, J.M. Hardwick, and M.J. Betenbaugh. 2003. A comparison of the properties of a Bcl-xL variant to the wild-type anti-apoptosis inhibitor in mammalian cell cultures. Metab. Eng. 5:230-245.
27. Zhou, H., Q. Hou, Y. Chai, and Y.T. Hsu. 2005. Distinct domains of Bcl-XL are involved in Bax and Bad antagonism and in apoptosis inhibition. Exp. Cell Res. 309:316-328.
28. Srivastava, R.K., Q.S. Mi, J.M. Hardwick, and D.L. Longo. 1999. Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. Proc. Natl. Acad. Sci. USA. 96:3775-3780.
29. Bassik, M.C., L. Scorrano, S.A. Oakes, T. Pozzan, and S.J. Korsmeyer. 2004. Phosphorylation of BCL-2 regulates ER Ca2+ homeostasis and apoptosis. EMBO J. 23:1207-1216.
30. Yamamoto, K., H. Ichijo, and S.J. Korsmeyer. 1999. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol. Cell. Biol. 19:8469-8478.
31. Deverman, B.E., B.L. Cook, S.R. Manson, R.A. Niederhoff, E.M. Langer, I. Rosova, L.A. Kulans, X. Fu, J.S. Weinberg, J.W. Heinecke, et al. 2002. Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell. 111:51-62.
32. Li, C., and C.B. Thompson. 2002. Cancer. DNA damage, deamidation, and death. Science. 298:1346-1347.
33. Clem, R.J., E.H. Cheng, C.L. Karp, D.G. Kirsch, K. Ueno, A. Takahashi, M.B. Kastan, D.E. Griffin, W.C. Earnshaw, M.A. Veliuona, and J.M. Hardwick. 1998. Modulation of cell death by Bcl-XL through caspase interaction. Proc. Natl. Acad. Sci. USA. 95:554-559.
34. Fujita, N., A. Nagahashi, K. Nagashima, S. Rokudai, and T. Tsuruo. 1998. Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases. Oncogene. 17:1295-1304.
35. Hildeman, D.A., T. Mitchell, B. Aronow, S. Wojciechowski, J. Kappler, and P. Marrack. 2003. Control of Bcl-2 expression by reactive oxygen species. Proc. Natl. Acad. Sci. USA. 100:15035-15040.
36. Ley, R., K. Balmanno, K. Hadfield, C. Weston, and S.J. Cook. 2003. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J. Biol. Chem. 278:18811-18816.
37. Qi, X.J., G.M. Wildey, and P.H. Howe. 2006. Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function. J. Biol. Chem. 281:813-823.
38. Mitchell, T.C., D. Hildeman, R.M. Kedl, T.K. Teague, B.C. Schaefer, J. White, Y. Zhu, J. Kappler, and P. Marrack. 2001. Immunological adjuvants promote activated T cell survival via induction of Bcl-3. Nat. Immunol. 2:397-402.
39. Naviaux, R.K., E. Costanzi, M. Haas, and I.M. Verma. 1996. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70:5701-5705.
40. Marrack, P., J. Kappler, and T. Mitchell. 1999. Type I interferons keep activated T cells alive. J. Exp. Med. 189:521-530.
41. Veis, D.J., C.L. Sentman, E.A. Bach, and S.J. Korsmeyer. 1993. Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J. Immunol. 151:2546-2554.
42. Kozono, H., J. White, J. Clements, P. Marrack, and J. Kappler. 1994. Production of soluble MHC class II proteins with covalently bound single peptides. Nature. 369:151-154.
43. Otwinowski, Z., and W. Minor. 1997. Processing of X-ray diffraction data collected in oscillation mode. In Macromolecular Crystallography Part A. C.W. Carter Jr. and R.M. Sweet, editors. Academic Press, New York. 307-326.
44. Collaborative Computational Project, Number 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50:760-763.
45. Navaza, J. 2001. Implementation of molecular replacement in AMoRe. Acta Crystallogr. D Biol. Crystallogr. 57:1367-1372.
46. Brunger, A.T., P.D. Adams, G.M. Clore, W.L. DeLano, P. Gros, R.W. Grosse-Kunstleve, J.S. Jiang, J. Kuszewski, M. Nilges, N.S. Pannu, et al. 1998. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54:905-921.
47. Guex, N., and M.C. Peitsch. 1997. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 18:2714-2723.
48. Martz, E. 2002. Protein Explorer: easy yet powerful macromolecular visualization. Trends Biochem. Sci. 27:107-109.